RESUMEN
BACKGROUND: Many adolescents affected by psychiatric disorders require pharmacological treatment. Knowing which medication is being used is of utmost importance. Our main objective was to gain insight into prescribing patterns at the Department of child and adolescent psychiatry, Clinical Hospital Centre Rijeka. In addition, we looked for potential differences between adolescents regarding their pharmacotherapy status. SUBJECTS AND METHODS: The data from medical charts of 227 adolescents (55% females), age 12-18 years (16.4±1.18) were analysed. All of them were treated as outpatients during one year period (2014/15). Medical charts were obtained from the computerized archive system of Clinical Hospital Centre. Prescribed drug patterns were taken into account if patients have been taking medication for at least one month. RESULTS: Most of the patients, 162 (71.4%), were treated with psychiatric medication. In the pharmacologically treated group, adolescents were older (t=-4.678; p<0.001), predominately male (χ2=5.175, p=0.023) and hospitalized (χ2=20.612, p<0.0001). Accordingly, male (OR=2.09, P<0.05) and hospitalized (OR=15.32, P<0.001) adolescents were more disposed to be medicated. Psychotic disorder was the most commonly diagnosed disorder (51 patients). There were 454 different prescribing patterns, mostly prescribed antipsychotics, 36.6% of all prescriptions; followed by 31.5% anxiolytics' and 23.7% antidepressants' prescriptions. However, number of patients receiving antipsychotics, anxiolytics and antidepressants was quite similar (103: 110: 99). The highest number of patients was treated with sertraline (58), followed by those treated with risperidone (48). Majority of the patients (104/227) were treated with polytherapy. CONCLUSION: Prescribing psychiatric pharmacotherapy for adolescents is a common clinical practice. Adolescents that were prescribed pharmacotherapy were significantly older; hospitalized and male adolescents were more prone to be medicated. Antipsychotics were most frequently prescribed drugs. The prescribing patterns are generally consistent with international trends and guidelines; however caution regarding high proportion of polytherapy is necessary.
Asunto(s)
Antipsicóticos , Pautas de la Práctica en Medicina , Trastornos Psicóticos , Adolescente , Psiquiatría del Adolescente , Antidepresivos , Antipsicóticos/uso terapéutico , Niño , Prescripciones de Medicamentos , Femenino , Humanos , Masculino , Trastornos Psicóticos/tratamiento farmacológico , RisperidonaRESUMEN
The aim of this research is to look into the roles of families' social situation and cohesion in adolescent auto-aggressiveness in Croatia. The research was conducted on a sample of Zagreb high school students which encompassed 701 pupils of both genders aged 14-19. The basic demographic data were obtained using the Structured Demographic and Family Data Questionnaire. Auto-aggressiveness was tested using a section of the Report on Youth Aged 11-18 and the Scale of Auto-destructiveness--SAD, whereas the family cohesion was tested with the Family Adaptability and Cohesion Evaluation Scales FACES III. The obtained results show differences according to the gender: girls are more prone to auto-aggressiveness than boys (t = -3.385, df = 565, p = 0.001) and girls more often show symptoms of destructiveness (t = -3.809, df = 637, p < 0.001) and anxiety (t = -6.562, df = 640, p < 0.001), while boys show pronounced aggressiveness (t = 2.655, df = 653, p = 0.008). Significant family factors associated with auto-aggressiveness are parents' marital status (chi2 = 18.039, df = 4, p = 0.001), their financial situation (F(2.548) = 4.604, p = 0.010), alcoholic father (chi2 = 9.270, df = 2, p = 0.010), mentally ill mother (t = 5.264, df = 541, p < 0.001), as well as mentally ill father (t = 4.744, df = 529, p < 0.001), and corporal punishment by mother (F(2.542) = 8.132, p < 0.001) or father (F(2.530) = 5.341, p = 0.005). Adolescents from split families show more auto-aggressiveness. Family cohesion appears to be considerably associated with auto-aggressiveness and the adolescents that see their families as less cohesive have more mental problems (chi2 = 29.98, df = 2, p < 0.001). There is a connection between auto-destructive behavior in adolescents and family factors. Knowledge of family's social situation and cohesion may help understand, prevent and treat auto-aggressiveness in adolescents.
Asunto(s)
Conducta del Adolescente , Agresión , Familia/psicología , Adolescente , Croacia , Femenino , Humanos , MasculinoRESUMEN
The aims of this study were to identify the aspects of family functioning which are associated with the course and remission of schizophrenia and to explore relations between aspects of family functioning and family history of schizophrenia. The subjects were 90 patients, treated at the Clinical hospital centre in Rijeka, Croatia, with diagnosed schizophrenia (F20.0 to F20.5) and without psychiatric comorbidity. The patients were organized into three groups depending on the treatment status during the calendar year that preceded the year in which the survey took place: patients with schizophrenia who received an outpatient care and were maintaining favourable remission, patients who were hospitalized once to twice and patients who were hospitalized at least three times in the precedent calendar year. The treatment status was used as an indicator of the course of the illness. A Family Functioning Scale was applied and the data on the absence/presence of schizophrenia in the family history were collected through the examination of previous medical records. The lowest prevalence of familial schizophrenia was found among the patients who were maintaining favourable remission. Among the three groups statistically significant differences were found regarding the following family functioning variables: expressiveness, family sociability, democratic family style. Also there were observed statistically significant differences in the family functioning depending on the presence/absence of the schizophrenia in the family history that included following domains: family cohesion, external locus of control and democratic family style. Our study gives support to the conclusion that family functioning of persons with schizophrenia differs depending on the course of the illness and presence/absence of schizophrenia in the family history.
Asunto(s)
Salud de la Familia , Relaciones Familiares , Esquizofrenia/diagnóstico , Adolescente , Adulto , Análisis de Varianza , Comorbilidad , Croacia , Femenino , Hospitalización , Humanos , Masculino , Pacientes Ambulatorios , Psicología del Esquizofrénico , Clase Social , Adulto JovenRESUMEN
BACKGROUND: Due to excessive concerns and focus on weight control and body shape, adolescents often resort to inappropriate behaviours and attitudes towards eating, resulting in physical and psychological issues. This study aimed to assess possible relationships and predictor variables between disordered eating and age, BMI, body appreciation, self-esteem, quality of family interactions, psychosocial health and childhood trauma experience in adolescents of both sexes in the city of Mostar (Bosnia and Herzegovina). MATERIALS AND METHODS: A cross-sectional study was carried out on a suitable sample of 724 high-school students aged 14-19 years. The following tools have been used: socio-demographic questionnaire, The Eating Attitudes Test (EAT-26), Body Mass Index (BMI), Body Appreciation Scale (BAS), Rosenberg's Self-Esteem Scale, Quality of Family Interaction Scale (KOBI), and Paediatric Quality of Life Inventory, version 4.0 (PedsQLTM) and Childhood trauma Questionnaire (CTQ). Collected data were analyzed in SPSS v. 20.0 software using Pearson's correlation coefficient and multiple regression analysis. RESULTS: Body appreciation is the most significant predictor for developing disordered eating across the entire sample of adolescents (ß = -0.325, P < 0.05) and individually for male adolescents (ß = -0.199, P = 0.010) and female adolescents (ß = -0.379, P < 0.001). In addition to this variable, BMI has proved to be a statistically significant predictor in explaining the eating behaviours of female adolescents (ß = 0.185, P < 0.001), while this happens to be self-esteem for male adolescents (ß = -0.211, P < 0.022). CONCLUSION: The most significant risk factors for developing disordered eating in adolescents are body appreciation, BMI and self-esteem. Results of this research can contribute to enhancement of intervention programmes which promote a positive body image and aim to prevent disordered eating in adolescents of both sexes.
RESUMEN
The selection of antipsychotics as medications used primarily for treating schizophrenia and disorders similar to schizophrenia is an important aspect of the treatment of forensicpatients. This study examines the effect of antipsychotics selection (typical or atipycal) on the level of aggressiveness, side effects and the hospitalisation length. The research is conducted on 98 psychiatric patients diagnosed with schizophrenia or similar disorders (F 20-F 29) in two forensic psychiatric institutions. The patients committed aggressive criminal offence in state of insanity. The patients are currently treated in inpatient psychiatric institutions. The research was conducted by using the Aggressiveness Questionnaire (AG-87), the Simpson-Angus Scale for the assessment of extrapyramidal side effects, the Barnes Akathisia Rating Scale for the assesment of akathisia and the Abnormal Involuntary Movement Scale. The results show no significant difference between the groups of patients treated with typical and atypical antipsychotics in all the variables.
Asunto(s)
Agresión/efectos de los fármacos , Antipsicóticos/uso terapéutico , Esquizofrenia/tratamiento farmacológico , Adulto , Anciano , Femenino , Humanos , Masculino , Persona de Mediana Edad , Pruebas Psicológicas , Psicología del EsquizofrénicoRESUMEN
The effects of psychological factors in alcoholics with malignant tumor of the oral cavity and oropharynx are scarcely explored. The aim of the research was to examine early family relations and investigate differences in the use of defense mechanisms in alcohol dependent patients suffering from malignant tumor of the oral cavity and oropharynx compared to alcohol dependent persons without malignant tumors and healthy controls. The research included 51 alcohol dependent patients treated for malignant tumor of the oral cavity and oropharynx at the University Hospital Center Rijeka from 2005 to 2009. The control groups corresponded to the experimental group in age, sex and education level. The research used a general demographic questionnaire, the Mini International Neuropsychiatric Interview and the Revised Questionnaire of Life Style and Defense Mechanisms. The research groups showed significant differences in difficult childhood (p < 0.001) including abuse (p = 0.004). The alcohol dependent persons suffering from malignant tumors of the oral cavity and oropharynx significantly less frequently used primitive defense mechanisms of regression (p = 0.004) and displacement (p = 0.013) compared to alcoholics without malignant tumors who significantly more often used neurotic defense mechanisms - compensation (p = 0.005) and intellectualization (p < 0.001). The earliest emotional experiences and quality of family relations affect the development of defense mechanisms. These are the psychological factors in the development of oropharyngeal cancer in alcohol addicts.
Asunto(s)
Alcoholismo/psicología , Mecanismos de Defensa , Neoplasias de la Boca/psicología , Neoplasias Orofaríngeas/psicología , Anciano , Femenino , Humanos , Masculino , Persona de Mediana EdadRESUMEN
Psychopharmaca are used in treatment of psychiatric illnesses and disorders, among other therapeutic possibilities. The choice of the psychopharmaca is determined by the specific psychopathology of the patient, within the diagnostic categories, according to the current classification of diseases and disorders. With the advances in pharmaco industry, the range of drugs used in the everyday clinical practice is occurring at a very rapid pace. Antipsychotic medications are used in treatment of mainly psychotic disorders. However, the new generation of antipsychotics, due to their specific receptor affinities, is sometimes used in treatment of affective disorders as well. We are reporting a case of a female patient who was hospitalized several times. Amisulpride was introduced in the treatment and due to a series of unfortunate events and changes that followed (i. e. frequent hospitalizations and changes of therapists, different mental institutions) dose of amisulpride was gradually increased to its antipsychotic doses, which did not help achieve therapeutic benefits, but serious side effects.
Asunto(s)
Antipsicóticos/efectos adversos , Trastornos de Ansiedad/tratamiento farmacológico , Trastorno Depresivo/tratamiento farmacológico , Hiperprolactinemia/inducido químicamente , Trastornos Somatomorfos/tratamiento farmacológico , Sulpirida/análogos & derivados , Amisulprida , Ansiolíticos/efectos adversos , Ansiolíticos/uso terapéutico , Antidepresivos/efectos adversos , Antidepresivos/uso terapéutico , Antipsicóticos/uso terapéutico , Trastornos de Ansiedad/diagnóstico , Trastornos de Ansiedad/psicología , Trastorno de Personalidad Limítrofe/diagnóstico , Trastorno de Personalidad Limítrofe/tratamiento farmacológico , Trastorno de Personalidad Limítrofe/psicología , Trastorno Depresivo/diagnóstico , Trastorno Depresivo/psicología , Relación Dosis-Respuesta a Droga , Sustitución de Medicamentos , Quimioterapia Combinada , Femenino , Galactorrea/inducido químicamente , Galactorrea/diagnóstico , Galactorrea/psicología , Humanos , Persona de Mediana Edad , Readmisión del Paciente , Trastornos Somatomorfos/diagnóstico , Trastornos Somatomorfos/psicología , Sulpirida/efectos adversos , Sulpirida/uso terapéuticoRESUMEN
Children and adolescents are being treated with antipsychotics more often than before, although the risk of adverse events in this age group still remains unclear. Because of increased use of antipsychotics in children and adolescents, their endocrine and metabolic side-effects (weight gain, obesity, and related metabolic deviations) are of particular worrying, especially within pediatric and adolescent population that appears to be at greater risk comparing with adults for antipsychotic-induced metabolic adverse events. In this work we will present the course of treatment of an adolescent girl with psychotic symptoms, within the clinical diagnosis of Organic delusional disorder, who had a considerable weight gain after one year of olanzapine treatment.
Asunto(s)
Antipsicóticos/efectos adversos , Benzodiazepinas/efectos adversos , Epilepsia/tratamiento farmacológico , Trastornos Neurocognitivos/tratamiento farmacológico , Aumento de Peso/efectos de los fármacos , Adolescente , Anticonvulsivantes/efectos adversos , Anticonvulsivantes/uso terapéutico , Antipsicóticos/uso terapéutico , Benzodiazepinas/uso terapéutico , Índice de Masa Corporal , Conducta Cooperativa , Preparaciones de Acción Retardada , Dibenzotiazepinas/efectos adversos , Dibenzotiazepinas/uso terapéutico , Sustitución de Medicamentos , Quimioterapia Combinada , Epilepsia/diagnóstico , Epilepsia/psicología , Femenino , Estudios de Seguimiento , Humanos , Comunicación Interdisciplinaria , Lamotrigina , Trastornos Neurocognitivos/diagnóstico , Trastornos Neurocognitivos/psicología , Olanzapina , Fumarato de Quetiapina , Triazinas/efectos adversos , Triazinas/uso terapéuticoRESUMEN
The treatment of dysthymia in itself poses a problem in the everyday psychiatric practice and it can be further hindered when accompanied by pronounced personality traits (which are indicative of disorder). Due to its pathology and duration dysthymia interferes with the patient's quality of life and the ability to function in some segments of everyday life. These interferences enticed our patient to opt for psychiatric treatment. During a three-year period, despite all the efforts made by psychiatrists in this comprehensive and challenging dysthymia treatment (psychotherapy, group psychotherapy, psychopharmacotherapy), the expected outcomes of the treatment did not occur. The patient's goals and expectations included lifestyle change, achieving life satisfaction and mood improvement. The patient was refusing suggested psychopharmaca until confronted, in psychotherapy, with the fact that she is the one prolonging her own helplessness and directing her passive agression at the members of the group. In the end the patent agreed to take psychopharmaca. Therefore, sertraline was introduced in the treatment, but the patient experienced a severe allergic reaction (Qiuncke's oedema). After four months the second attempt was made and escitaloptam was introduced, which resulted in urticaria. Due to these allergic reactions to antidepressants, the patient decided not to pursue the psychopharmacological treatment.
Asunto(s)
Antidepresivos/efectos adversos , Citalopram/efectos adversos , Erupciones por Medicamentos/etiología , Hipersensibilidad a las Drogas/etiología , Trastorno Distímico/tratamiento farmacológico , Sertralina/efectos adversos , Adulto , Angioedema/inducido químicamente , Angioedema/diagnóstico , Antidepresivos/uso terapéutico , Citalopram/uso terapéutico , Terapia Combinada , Erupciones por Medicamentos/diagnóstico , Hipersensibilidad a las Drogas/diagnóstico , Trastorno Distímico/psicología , Femenino , Humanos , Psicoterapia , Psicoterapia de Grupo , Sertralina/uso terapéuticoRESUMEN
Integrative approach to treatment of psychiatric patients incorporates a variety of therapeutic procedures that overlap and are not mutually exclusive. Their objective is unique: to heal and to restore patients' proper functioning in their family, work and social environments alike. Treatment often requires integration of various therapeutic approaches. In this paper we report the efficacy of an integrative model in the case of a female patient who developed a clinical picture of psychotic depression after giving birth. Taking an individual approach alongside the continuous use of psycho pharmacotherapy enabled us to look for an appropriate model of hospital and ambulatory treatment, namely psychotherapeutic setting. This example proved individual psychotherapy to be a complementary method to psycho pharmacotherapy. This was due to a strong feeling of shame that prevented the patient from opening up and dealing with her inner conflict in the previous group treatment. Integrative and personalised treatment has resulted in a relatively quick recovery and return to her everyday duties.
Asunto(s)
Trastornos Psicóticos Afectivos/rehabilitación , Depresión Posparto/rehabilitación , Grupo de Atención al Paciente , Adulto , Antidepresivos/uso terapéutico , Terapia Combinada , Conducta Cooperativa , Croacia , Centros de Día , Quimioterapia Combinada , Femenino , Estudios de Seguimiento , Hospitalización , Humanos , Comunicación Interdisciplinaria , PsicoterapiaRESUMEN
In clinical practice with adolescents we often come across with prepsychotic and psychotic disorders. When an adolescent patient has a positive hereditary burden for psychiatric illnesses in both parents, then the qualification of adolescent's mental disorder seems closer to psychotic. We must have in mind that hereditary burden is only one of many etiological factors that contribute to mental decompensations in adolescent age, that can, but don't have to be the prodrome of psychosis in the future. Whether is characterised as psychotic or not, the treatment of an adolescent in critical situation must be personalised, considering biological, social and individual factors of a patient. We believe that clinician's experience in treating psychotic adolescent patients and personalised and integrative approach to a patient is of great importance. In this article we will present the therapeutical process of a 19-year old female adolescent, with psychotic symptoms, whose both parents are psychiatric patients. A personalised and integrative approach in treatment of this patient made possible the overcome of crisis, termination of high school education and an employment. These achievements, no matter what the future can bring to this patient, create better conditions for her functioning in life.
Asunto(s)
Hijo de Padres Discapacitados/psicología , Conflicto Familiar/psicología , Grupo de Atención al Paciente , Medicina de Precisión , Trastornos Psicóticos/genética , Trastornos Psicóticos/terapia , Trastorno de la Personalidad Esquizotípica/genética , Trastorno de la Personalidad Esquizotípica/terapia , Niño , Terapia Combinada , Conducta Cooperativa , Femenino , Humanos , Comunicación Interdisciplinaria , Psicoterapia/métodos , Psicoterapia de Grupo/métodos , Trastornos Psicóticos/psicología , Psicotrópicos/uso terapéutico , Factores de Riesgo , Trastorno de la Personalidad Esquizotípica/psicología , Adulto JovenRESUMEN
Mood disturbances are characteristic and dominant feature of Mood disorders. Bipolar Affective Disorder (BAD) is a mood disorder which occurs equally in both sexes. BAD may occur in co morbidity with other mental diseases and disorders such as: Anorexia Nervosa, Bulimia Nervosa, Attention Deficit, Panic Disorder and Social Phobia. However, medical disorders (one or more) can also coexist with BAD. Metabolic syndrome is a combination of metabolic disorders that increase the risk of developing cardiovascular disease. A 61-year old female patient has been receiving continuous and systematic psychiatric treatment for Bipolar Affective Disorder for the last 39 years. The first episode was a depressive one and it occurred after a child delivery. Seventeen years ago the patient developed diabetes (diabetes type II), and twelve years ago arterial hypertension was diagnosed. High cholesterol and triglyceride levels as well as weight gain were objective findings. During the last nine years she has been treated for lower leg ulcer. Since metabolic syndrome includes abdominal obesity, hypertension, diabetes mellitus, increased cholesterol and serum triglyceride levels, the aforesaid patient can be diagnosed with Metabolic Syndrome. When treating Bipolar Affective Disorder, the antipsychotic drug choice should be careful and aware of its side-effects in order to avoid the development or aggravation of metabolic syndrome.
Asunto(s)
Antipsicóticos/efectos adversos , Trastorno Bipolar/tratamiento farmacológico , Síndrome Metabólico/inducido químicamente , Antipsicóticos/uso terapéutico , Trastorno Bipolar/sangre , Trastorno Bipolar/diagnóstico , Trastorno Bipolar/genética , Glucemia/metabolismo , Terapia Combinada , Comorbilidad , Quimioterapia Combinada , Femenino , Humanos , Estilo de Vida , Cuidados a Largo Plazo , Síndrome Metabólico/sangre , Síndrome Metabólico/diagnóstico , Síndrome Metabólico/terapia , Persona de Mediana Edad , Readmisión del PacienteRESUMEN
Patients' non-compliance in treatments, such as irregular taking of medication, represents an enormous problem with psychiatric patients in general. This difficulty occurs especially in patients suffering from chronic mental illnesses such as schizophrenia. There are not any significant differences in the efficacy of reducing the positive symptoms in schizophrenia between the conventional and the atypical antipsychotics. However, the effects which are manifested in negative schizophrenia symptoms or in the patients' cognitive functioning, favour the atypical antipsychotics. When it comes to adding the subjective well-being of the patients and their improvement of the quality of life, then, the advantages of atypical antipsychotics are unquestionable. New trends in medicine are increasingly impinge on the pharmacoeconomy, which aims at reducing treatment cost. This trend is getting progressively stronger in the world and as such, it certainly will not bypass Croatia. Pharmacists and General Practice doctors (GP) are permitted, by the law, to replace the original medicament prescribed by a specialist doctor, with a cheaper one from the same generic group of medicaments, with a purpose of cutting down the treatment costs. Is there always a valid justification for such practice, and should it become a rule for all the patients out there? This is a case report of a patient who suffers from paranoid schizophrenia. He has been on a treatment with atypical antipsychotics and has kept in a good and stable remission for the past seven years. His therapy consisted of olanzapine in a dose of 15 mg in the evening, throughout the whole period of his 7-year remission. A month ago, his GP doctor self- initially prescribed a generic olanzapine. The impact of this decision on to the mental state of the patient as well as his trust in the treatment itself is described in this report.
Asunto(s)
Antipsicóticos/economía , Antipsicóticos/uso terapéutico , Benzodiazepinas/economía , Benzodiazepinas/uso terapéutico , Costos de los Medicamentos/legislación & jurisprudencia , Medicamentos Genéricos/economía , Medicamentos Genéricos/uso terapéutico , Esquizofrenia Paranoide/tratamiento farmacológico , Adulto , Enfermedad Crónica , Trastornos del Conocimiento/tratamiento farmacológico , Ahorro de Costo/legislación & jurisprudencia , Croacia , Quimioterapia Combinada , Medicina Familiar y Comunitaria/economía , Medicina Familiar y Comunitaria/legislación & jurisprudencia , Humanos , Masculino , Cumplimiento de la Medicación/psicología , Olanzapina , Readmisión del Paciente/economía , Calidad de Vida/psicología , Esquizofrenia Paranoide/economía , Resultado del TratamientoRESUMEN
Antipsychotics side-effects pose an enormous problem in psychiatric treatment. The choice of antipsychotics is a crucial issue in the treatment as both patients' cooperation and compliance often depend upon it. Severe side-effects might sometimes cause the treatment interruption, to which each patient is entitled. Schizotypal personality disorder (SPD) features include social and interpersonal deficits, discomfort with close relationships, as well as cognitive and perceptual distortions and eccentricities of behaviour. Dominant symptoms often determine psycho pharmacotherapy and therefore antipsychotic treatment is possible. A 23 year-old man was treated for 4 months due to disturbances typical for SPD. Since the patient did not respond well to haloperidol, zuclopenthixol was advised. The latter medication produced severe, life-threatening side-effects which caused urgent hospitalisation. Althouth zuclopenthixol was instantly retracted from the therapy, the patient and his family rejected any further psychiatric treatment. In spite the fact that hetero-data obtained from his mother a few months later, revealed disturbances which greatly affected the patient's live, the patient showed resistance to further psychiatric treatment because of his negative experience with this medication.
Asunto(s)
Antipsicóticos/toxicidad , Clopentixol/toxicidad , Hipersensibilidad a las Drogas/psicología , Cumplimiento de la Medicación/psicología , Trastorno de la Personalidad Esquizotípica/tratamiento farmacológico , Trastorno de la Personalidad Esquizotípica/psicología , Antipsicóticos/uso terapéutico , Clopentixol/uso terapéutico , Croacia , Humanos , Masculino , Trastorno de la Personalidad Esquizotípica/diagnóstico , Negativa del Paciente al Tratamiento/psicología , Adulto JovenRESUMEN
The use of antipsychotics in treatment of children and adolescents requires good knowledge of psychopathology, psychofarmacotherapy, developmental processes and family relations. It is necessary to have parental consent for the use of a medication in this age, with previous explanation of therapeutic goals, limitations and possible side effects of antipsychotics. The number of antipsychotics registered for use in children and adolescents is quite limited. The combination of clinical experience of those working with psychotic adolescents and a good collaboration with parents, creates a therapeutic space where good results in treatment can be achieved. Side effects, though rarely, can bring in question the course of treatment and disorder follow up. In this work we will present a 14-year old girl adolescent with psychotic symptoms, in which case the course of treatment and discontinuance of therapy was caused by a side effect - an oculogyric crisis.
Asunto(s)
Antipsicóticos/efectos adversos , Enfermedades de los Ganglios Basales/inducido químicamente , Medicamentos Genéricos/efectos adversos , Cumplimiento de la Medicación/psicología , Trastornos de la Motilidad Ocular/inducido químicamente , Trastornos Psicóticos/tratamiento farmacológico , Risperidona/efectos adversos , Adolescente , Antipsicóticos/uso terapéutico , Enfermedades de los Ganglios Basales/psicología , Medicamentos Genéricos/uso terapéutico , Femenino , Hospitalización , Humanos , Trastornos de la Motilidad Ocular/psicología , Pacientes Desistentes del Tratamiento/psicología , Trastornos Psicóticos/psicología , Risperidona/uso terapéutico , Negativa del Paciente al Tratamiento/psicologíaRESUMEN
New trends in medicine which are much more oriented towards pharmacoeconomy, are ever so common these days. There's an aim within the focus of the health system which is cutting down treatment expenses, and that relates to psychiatry practice too. Prescription drugs issued by specialist doctors are allowed to be switched with cheaper ones of the same group of drugs by GP doctors, with an aim of cost reduction. "Instead of the medicament prescribed, a GP doctor is allowed to prescribe an alternative medicament of the same efficacy in the dosage of an adequate strength" (taken from the specialist medical report form). A 74 years old man is treated for psychotic depression. Exogenic environmental factors caused the symptoms manifestation due to which hospitalization in a psychiatric ward occurred in two incidences. At the risperidone introduction soon after the second hospitalization event, a long term remission was obtained which lasted for several years. Despite a stable dose of psychopharmacs, new episode of the illness occurred. Researching the potential factors which lead towards the aggravation of the course of the illness disclosed that instead of the original risperidone, the pharmacist issued a generic in an equivalent dose.
Asunto(s)
Trastornos Psicóticos Afectivos/tratamiento farmacológico , Antipsicóticos/efectos adversos , Antipsicóticos/economía , Trastorno Depresivo Mayor/tratamiento farmacológico , Costos de los Medicamentos/legislación & jurisprudencia , Medicamentos Genéricos/efectos adversos , Medicamentos Genéricos/economía , Medicamentos bajo Prescripción/efectos adversos , Medicamentos bajo Prescripción/economía , Risperidona/efectos adversos , Risperidona/economía , Anciano , Antipsicóticos/uso terapéutico , Ahorro de Costo/legislación & jurisprudencia , Croacia , Medicamentos Genéricos/uso terapéutico , Medicina Familiar y Comunitaria/economía , Medicina Familiar y Comunitaria/legislación & jurisprudencia , Hospitalización , Humanos , Masculino , Medicamentos bajo Prescripción/uso terapéutico , Recurrencia , Risperidona/uso terapéutico , Equivalencia Terapéutica , Insuficiencia del TratamientoRESUMEN
Posttraumatic stress syndrome (PTSD) is a disorder which emerges after the patient has experienced one or more psychotraumatic events, which equally include neurobiological deregulation and psychological dysfunction. Comorbidity is present in more than 80% of the diagnosed cases of PTSD, which makes treatment of the primary disorder very difficult. It has been identified that PTSD can be found in comorbidity with other psychiatric disorders as well as with physical illnesses. This study presents aged 42, who has been psychiatrically treated for the past 12 years, with a diagnose of chronic PTSD and who subsequently developed depression. The patient has been treated for psoriasis for the past seven years, and two years ago, had to undergo surgery due to bladder carcinoma, followed by a radiotherapy course. Multiple comorbidity significantly makes the treatment of the primary illness very difficult and it limits the choice of pharmacotherapy in ambulatory conditions.
Asunto(s)
Ansiolíticos/uso terapéutico , Antidepresivos/uso terapéutico , Trastornos de Combate/tratamiento farmacológico , Trastornos de Combate/epidemiología , Trastorno Depresivo/epidemiología , Diazepam/uso terapéutico , Psoriasis/epidemiología , Neoplasias de la Vejiga Urinaria/epidemiología , Adulto , Ansiolíticos/efectos adversos , Antidepresivos/efectos adversos , Terapia Combinada , Comorbilidad , Trastorno Depresivo/tratamiento farmacológico , Diazepam/efectos adversos , Erupciones por Medicamentos/diagnóstico , Erupciones por Medicamentos/epidemiología , Quimioterapia Combinada , Humanos , Masculino , Inventario de Personalidad/estadística & datos numéricos , Psoriasis/diagnóstico , Psicometría , Psicoterapia , Neoplasias de la Vejiga Urinaria/diagnósticoRESUMEN
OBJECTIVE: The aim of this study was to explore the effectiveness and tolerability of long-acting paliperidone palmitate antipsychotic in adolescent first-episode schizophrenia patients while comparing the results with the oral antipsychotic risperidone. METHODS: This study is a retrospective, noninterventional study to assess the effectiveness and tolerability of long-acting injectable antipsychotic paliperidone palmitate in first-episode adolescent patients during the first 12 months of treatment compared with the oral antipsychotic risperidone. The data include general sociodemographic characteristics, number of hospitalizations, side effects, and the following clinical scales: Positive and Negative Syndrome Scale (PANSS), Personal and Social Performance Scale (PSP), Clinical Global Impression Improvement and Severity (CGI-I and CGI-S), and Treatment Satisfaction Questionnaire for Medication (TSQM). RESULTS: During the 12-month study period significant improvement was registered in patients receiving both paliperidone palmitate and risperidone in the following scales: PANSS, PSP, CGI-I, and CGI-S. Patients receiving paliperidone palmitate had significantly greater improvement in PANSS, CGI-S, and PSP compared with the risperidone group. Patients receiving risperidone had significantly higher number of hospitalizations than the patients receiving paliperidone palmitate. The TSQM revealed that the patients who were receiving paliperidone palmitate achieved significantly higher scores on the convenience scale, global satisfaction, and on the overall result, whereas no difference was observed on the effectiveness scale. There were several side effects reported for paliperidone (5.5% hyperprolactinemia, 5.5% weight gain) and risperidone (5.5% hyperprolactinemia, 16.7% weight gain). CONCLUSIONS: In conclusion, paliperidone palmitate seems to be safe and effective in adolescent patients. Furthermore, it compared favorably with risperidone in the clinical response, side effects, and hospitalizations.
Asunto(s)
Antipsicóticos/uso terapéutico , Palmitato de Paliperidona/uso terapéutico , Risperidona/uso terapéutico , Esquizofrenia/tratamiento farmacológico , Adolescente , Antipsicóticos/efectos adversos , Escalas de Valoración Psiquiátrica Breve/estadística & datos numéricos , Femenino , Hospitalización/estadística & datos numéricos , Humanos , Hiperprolactinemia/inducido químicamente , Masculino , Palmitato de Paliperidona/efectos adversos , Estudios Retrospectivos , Aumento de Peso/efectos de los fármacosRESUMEN
AIM: To assess psychological problems in children as reported by their veteran fathers with war-related posttraumatic stress disorder (PTSD). METHOD: The study group consisted of 154 veterans with war-related PTSD who were treated at the Mostar University Hospital. The control group consisted of 77 veterans without war-related PTSD who were selected from veteran associations by the snowball method. General Demographic Questionnaire, the first and fourth module of the Harvard Trauma Questionnaire-Bosnia and Herzegovina version, and the Questionnaire on Developmental, Emotional, and Behavioral Problems in Children, created specifically for the needs of this study, were used to collect data on veterans' perception of psychological problems in their children. RESULTS: In comparison with veterans without PTSD, veterans with PTSD reported significantly more developmental (odds ratio [OR], 2.37; 95% confidence interval [CI], 1.51-3.73), behavioral (OR, 3.92; 95% CI, 1.53-10.03), and emotional problems (OR, 17.74; 95% CI, 2.40-131.10) in their children. CONCLUSION: Veterans with war-related PTSD more often reported developmental problems in their children. Father's PTSD may have long-term and long-lasting consequences on the child's personality.
Asunto(s)
Trastornos por Estrés Postraumático/complicaciones , Estrés Psicológico/complicaciones , Veteranos , Guerra , Heridas y Lesiones/complicaciones , Bosnia y Herzegovina , Estudios Transversales , Humanos , Masculino , Persona de Mediana Edad , Pruebas Psicológicas , Psicometría , Trastornos por Estrés Postraumático/psicología , Estrés Psicológico/psicología , Encuestas y Cuestionarios , Heridas y Lesiones/psicologíaRESUMEN
The presence of psychotic symptoms in post-traumatic stress disorder (PTSD) has already been recognized. Using the Structured Clinical Interview Diagnostic and Statistical Manual, we searched for and assessed psychotic symptoms in 91 males suffering from combat-related PTSD. Hallucinations and delusions were present in 20% of patients. We divided all patients into three groups: the group with hallucinations and delusions, the group without these symptoms, and the group with "subthreshold" psychotic symptoms. Using the Harvard Trauma Questionnaire, Clinician-Administered PTSD Scale, and Structured Clinical Interview Diagnostic and Statistical Manual, we investigated differences between groups in the intensity of traumatization, severity of PTSD symptoms, and the frequency of depression. There were no significant differences between groups; however, there was one exception: severity of hyperarousal symptoms was positively correlated with occurrence of psychotic symptoms.